Transformation Capital is a growth and expansion firm based in Boston, Massachusetts, founded in 2016 by Todd Cozzens and Jared Kesselheim, MD. The company focuses on investing in healthcare sector companies throughout the United States. As a Registered Investment Adviser, Transformation Capital operates independently, having evolved from its predecessor, Leerink Transformation Partners LLC. The firm maintains a collaborative relationship with its former affiliate, SVB Leerink, which provides operational support and strategic advantages. With a commitment to fostering innovation in healthcare, Transformation Capital is positioned to manage investment portfolios effectively while leveraging its extensive industry expertise.
World Class Health is a healthcare technology company that connects self-funded employers with top-tier medical facilities, known as Centers of Excellence, for complex medical procedures. Its platform facilitates data sharing, offers personalized advice from healthcare professionals, and provides regular check-ins, helping employers reduce healthcare costs and enhance clinical outcomes.
Rad AI
Series C in 2025
Rad AI, Inc. is a company based in Berkeley, California, that specializes in developing an artificial intelligence platform designed to automate report generation for radiologists. Founded in 2018, Rad AI's solution streamlines the radiology workflow by automating repetitive tasks, thereby enhancing efficiency and accuracy while addressing issues of clinician burnout. The platform utilizes AI to generate report impressions, allowing radiologists to dictate findings using voice recognition technology, identify errors, and customize recommendations. By integrating smoothly with existing workflows, Rad AI aims to improve patient care and support radiologists in delivering accurate and timely reports.
Citizen Health
Seed Round in 2024
Over 350+ million people worldwide are affected by one of the 10,000+ rare diseases of which 95% do not have a single treatment available. Through our AI-powered platform, we liberate and structure data to radically improve rare and complex disease treatment, widen access to expert care, and revolutionize the development of new medicines at a fraction of the speed previously proven possible. Patients can share their health data across our multi-sided platform with caregivers, providers and researchers to illuminate better treatment and support options, while bringing therapies to patients faster. We support thousands of patients, work with a rapidly growing network of patient advocacy organizations, and innovate with leading biopharma organizations to accelerate therapies, always ensuring patients remain at the center.
Amino
Venture Round in 2024
Amino Inc. operates an online platform designed to assist users in finding doctors, comparing their qualifications, and scheduling appointments across the United States. The platform enables patients to search for healthcare providers based on specific conditions, procedures, and specialties. In addition to this, Amino functions as a healthcare financial wellness platform, helping companies and their employees navigate the complexities of the U.S. healthcare system. It focuses on delivering data-driven, personalized care recommendations that encourage plan members to seek high-value healthcare options. Through its services, Amino aims to make healthcare more intuitive, accessible, and convenient for patients. The company, originally known as Pare Labs, Inc., was incorporated in 2013 and rebranded to Amino in 2014, with its headquarters located in San Francisco, California.
Citizen Health
Seed Round in 2023
Over 350+ million people worldwide are affected by one of the 10,000+ rare diseases of which 95% do not have a single treatment available. Through our AI-powered platform, we liberate and structure data to radically improve rare and complex disease treatment, widen access to expert care, and revolutionize the development of new medicines at a fraction of the speed previously proven possible. Patients can share their health data across our multi-sided platform with caregivers, providers and researchers to illuminate better treatment and support options, while bringing therapies to patients faster. We support thousands of patients, work with a rapidly growing network of patient advocacy organizations, and innovate with leading biopharma organizations to accelerate therapies, always ensuring patients remain at the center.
DexCare
Series C in 2023
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.
Amino
Venture Round in 2023
Amino Inc. operates an online platform designed to assist users in finding doctors, comparing their qualifications, and scheduling appointments across the United States. The platform enables patients to search for healthcare providers based on specific conditions, procedures, and specialties. In addition to this, Amino functions as a healthcare financial wellness platform, helping companies and their employees navigate the complexities of the U.S. healthcare system. It focuses on delivering data-driven, personalized care recommendations that encourage plan members to seek high-value healthcare options. Through its services, Amino aims to make healthcare more intuitive, accessible, and convenient for patients. The company, originally known as Pare Labs, Inc., was incorporated in 2013 and rebranded to Amino in 2014, with its headquarters located in San Francisco, California.
Memora Health
Venture Round in 2023
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
Tebra Technologies
Series B in 2022
Tebra Technologies is a provider of digital tools and support designed to assist independent healthcare practices in navigating the complexities of the modern healthcare landscape. The company has developed a comprehensive medical technology platform that enables these practices to enhance patient acquisition, streamline care management through a fully certified electronic health record system, and improve patient engagement and billing processes. By consolidating essential functions into a single, efficient system, Tebra aims to empower healthcare professionals to optimize their operations and achieve greater success in a fragmented industry.
H1.co
Series C in 2022
H1 is a New York-based healthcare platform founded in 2017 that serves as a connector for life sciences companies, hospitals, academic medical centers, and health systems. Its platform specializes in providing real-time data and analytics to facilitate informed decision-making throughout the therapeutic development process, from fundraising to product launch. By offering insights on healthcare professionals, clinical research, and industry experts, H1 enables organizations to benchmark their performance and access critical information that accelerates the discovery and development of therapies aimed at combating diseases. The company positions itself as a trusted source within the healthcare ecosystem, leveraging data to enhance collaboration and innovation across the industry.
Memora Health
Venture Round in 2022
Memora Health Inc., founded in 2016 and based in San Francisco, California, develops an enterprise healthcare productivity platform aimed at automating outpatient communication and enhancing care delivery. The company partners with health systems, health plans, and digital health organizations to streamline clinical workflows, allowing clinicians to focus on their primary responsibilities while proactively engaging patients throughout their care journeys. Memora's platform digitizes high-touch processes, intelligently triaging patient-reported data to the relevant care team members and facilitating proactive, two-way communication between patients and providers. By transforming the way care is delivered, Memora Health seeks to make healthcare more actionable, accessible, and continuous.
DexCare
Series B in 2022
DexCare is a Seattle-based company founded in 2021 that specializes in providing a platform-as-a-service solution for managing health system capacity and demand across various lines of care. The company's platform aims to transform traditional patient-to-provider relationships into scalable digital experiences, thereby increasing revenue from new patients while reducing acquisition costs. By optimizing access to healthcare services, DexCare helps healthcare institutions generate new patients, enhance satisfaction, achieve cost savings, and ensure that patients receive timely and effective care.
Sword Health
Series D in 2021
Sword Health is a digital health company specializing in physical rehabilitation. It employs artificial intelligence to deliver personalized care to patients worldwide, anytime, anywhere. The platform offers interactive exercise routines supervised by remote physiotherapists, aiming to reduce costs and improve accessibility to physical therapy. Clinicians can utilize the data collected to enhance decision-making processes.
H1.co
Series C in 2021
H1 is a New York-based healthcare platform founded in 2017 that serves as a connector for life sciences companies, hospitals, academic medical centers, and health systems. Its platform specializes in providing real-time data and analytics to facilitate informed decision-making throughout the therapeutic development process, from fundraising to product launch. By offering insights on healthcare professionals, clinical research, and industry experts, H1 enables organizations to benchmark their performance and access critical information that accelerates the discovery and development of therapies aimed at combating diseases. The company positions itself as a trusted source within the healthcare ecosystem, leveraging data to enhance collaboration and innovation across the industry.
Sword Health
Series C in 2021
Sword Health is a digital health company specializing in physical rehabilitation. It employs artificial intelligence to deliver personalized care to patients worldwide, anytime, anywhere. The platform offers interactive exercise routines supervised by remote physiotherapists, aiming to reduce costs and improve accessibility to physical therapy. Clinicians can utilize the data collected to enhance decision-making processes.
Unite Us
Series C in 2021
Unite Us is a veteran-led technology company founded in 2013 in New York, specializing in creating coordinated care networks that connect health and social service providers. The company develops a platform that enables providers to send and receive secure referrals, track individuals' health journeys, and report on outcomes across a variety of services. By integrating social determinants of health into patient care, Unite Us facilitates a cohesive and collaborative ecosystem that enhances the ability of communities to deliver services effectively. This innovative approach moves beyond traditional resource directories, allowing systems to measure impact and improve health outcomes on a larger scale.
Sword Health
Series B in 2021
Sword Health is a digital health company specializing in physical rehabilitation. It employs artificial intelligence to deliver personalized care to patients worldwide, anytime, anywhere. The platform offers interactive exercise routines supervised by remote physiotherapists, aiming to reduce costs and improve accessibility to physical therapy. Clinicians can utilize the data collected to enhance decision-making processes.
H1.co
Series B in 2020
H1 is a New York-based healthcare platform founded in 2017 that serves as a connector for life sciences companies, hospitals, academic medical centers, and health systems. Its platform specializes in providing real-time data and analytics to facilitate informed decision-making throughout the therapeutic development process, from fundraising to product launch. By offering insights on healthcare professionals, clinical research, and industry experts, H1 enables organizations to benchmark their performance and access critical information that accelerates the discovery and development of therapies aimed at combating diseases. The company positions itself as a trusted source within the healthcare ecosystem, leveraging data to enhance collaboration and innovation across the industry.
Datavant
Series B in 2020
Datavant, Inc. is a health data platform company based in San Francisco, California, founded in 2017. The company specializes in aggregating and analyzing biomedical data using machine learning to enhance the efficiency of drug development. It focuses on improving the clinical trial process by employing artificial intelligence and organizing healthcare data to derive actionable insights for trial design and interpretation. By facilitating secure and accessible data connectivity, Datavant enables over 60 million healthcare records to be exchanged among thousands of organizations, including more than 70,000 hospitals and clinics. The company serves the clinical development and commercial pharmaceutical sectors, as well as researchers, and aims to improve patient outcomes while protecting patient privacy through its innovative platform.
PatientPing
Series C in 2020
PatientPing, Inc. is a health technology company that has established a national care coordination network designed to connect healthcare providers with real-time notifications whenever patients receive care. The network encompasses a diverse group of healthcare personnel, including physicians, nurses, case managers, and care coordinators across various settings such as hospitals, emergency departments, and skilled nursing facilities. PatientPing offers technology solutions tailored to Accountable Care Organizations (ACOs) and other healthcare providers, facilitating improved collaboration and information sharing. One of its key tools, Spotlights, leverages real-time data to identify utilization and performance trends in patient care. Founded in 2013 and headquartered in Boston, Massachusetts, PatientPing operates as a subsidiary of SVB Leerink Holdings LLC and maintains a strategic partnership with MedAllies, Inc. By fostering connections among care teams, PatientPing aims to enhance the quality and efficiency of healthcare delivery, ultimately leading to better patient outcomes.
PlushCare
Series B in 2020
PlushCare, Inc. is a telemedicine provider based in San Francisco, California, established in 2013. The company offers a virtual primary care platform that connects patients with board-certified doctors through video chat. Users can schedule online appointments to receive diagnoses, treatment plans, and prescriptions for a range of medical issues, including chronic conditions and urgent care needs. With a focus on delivering a friendly and personalized healthcare experience, PlushCare has served over 100,000 patients, receiving high ratings for customer satisfaction. The platform also includes services for mental health treatment and has developed at-home testing for Coronavirus.
Vera Whole Health
Venture Round in 2020
Vera Whole Health Inc., also known as Vera Fitness, Inc., is a Seattle-based company that provides comprehensive worksite primary care services through employer-funded clinics. Founded in 2007, Vera Whole Health offers a range of medical services including comprehensive physical exams, episodic sick care, pediatric care, chronic disease management, and preventive services such as health coaching and biometric screenings. The company also addresses urgent care needs, occupational health, and provides coordination of specialty and acute care. Vera Whole Health emphasizes patient engagement and population health management, aiming to improve health outcomes and promote overall well-being among employees. Through its strategic collaboration with Premera Blue Cross, Vera Whole Health seeks to deliver accessible and affordable healthcare solutions to employers and their employees.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.